Follow
Hector Chinoy
Hector Chinoy
Verified email at manchester.ac.uk - Homepage
Title
Cited by
Cited by
Year
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
IE Lundberg, A Tjärnlund, M Bottai, VP Werth, C Pilkington, M De Visser, ...
Arthritis & rheumatology 69 (12), 2271-2282, 2017
13892017
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
5072021
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
H Chinoy, N Fertig, CV Oddis, WER Ollier, RG Cooper
Annals of the rheumatic diseases 66 (10), 1345-1349, 2007
4132007
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
3162022
Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis
H Gunawardena, LR Wedderburn, H Chinoy, ZE Betteridge, J North, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
2632009
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis …
R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ...
Arthritis & Rheumatology 69 (5), 898-910, 2017
256*2017
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
JB Lilleker, J Vencovsky, G Wang, LR Wedderburn, LP Diederichsen, ...
Annals of the rheumatic diseases 77 (1), 30-39, 2018
2502018
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
M Jani, A Barton, RB Warren, CEM Griffiths, H Chinoy
Rheumatology 53 (2), 213-222, 2014
2502014
Phenotype standardization for statin‐induced myotoxicity
A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ...
Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014
2462014
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
Z Betteridge, S Tansley, G Shaddick, H Chinoy, RG Cooper, RP New, ...
Journal of autoimmunity 101, 48-55, 2019
2412019
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis
H Gunawardena, LR Wedderburn, J North, Z Betteridge, J Dunphy, ...
Rheumatology 47 (3), 324-328, 2008
2412008
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target …
ZE Betteridge, H Gunawardena, H Chinoy, J North, WER Ollier, ...
Annals of the rheumatic diseases 68 (10), 1621-1625, 2009
1972009
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)
LC Coates, T Aslam, F Al Balushi, AD Burden, E Burden‐The, ...
British Journal of Dermatology 168 (4), 802-807, 2013
1882013
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic …
S Rothwell, RG Cooper, IE Lundberg, FW Miller, PK Gregersen, J Bowes, ...
Annals of the rheumatic diseases 75 (8), 1558-1566, 2016
1682016
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
M Bottai, A Tjärnlund, G Santoni, VP Werth, C Pilkington, M De Visser, ...
RMD open 3 (2), e000507, 2017
1632017
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis …
H Chinoy, F Salway, N Fertig, N Shephard, BD Tait, W Thomson, ...
Arthritis research & therapy 8, 1-9, 2005
1592005
Genome‐wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders
FW Miller, RG Cooper, J Vencovský, LG Rider, K Danko, LR Wedderburn, ...
Arthritis & Rheumatism 65 (12), 3239-3247, 2013
1582013
Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases
MK Herbert, J Stammen-Vogelzangs, MM Verbeek, A Rietveld, ...
Annals of the rheumatic diseases 75 (4), 696-701, 2016
1502016
Interaction of HLA-DRB1* 03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study
H Chinoy, S Adimulam, F Marriage, P New, M Vincze, E Zilahi, A Kapitány, ...
Annals of the rheumatic diseases 71 (6), 961-965, 2012
1482012
Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes
FW Miller, W Chen, TP O'Hanlon, RG Cooper, J Vencovsky, LG Rider, ...
Genes & Immunity 16 (7), 470-480, 2015
1362015
The system can't perform the operation now. Try again later.
Articles 1–20